The aim of our in vivo package is to take your product from cellular level to clinical phase. We focus on translational, species-independent models and use advanced tools in order to provide layers of independent supportive data.
Our Added Value
The ability to provide concrete evidence depends on advanced and usable evaluation at each step of the process.
Thus, we perform angiogram and laser doppler imaging, along with behavioral and cognitive evaluations during and following the treatment phase and unique immunohistopathology following the treatment.
We have comprehensive ischemic models for various indications:
- Peripheral Vascular Models
- Stroke Models
- Ischemic Heart Disease
- Ischemic Diabetic Wounds
- Complementary Ischemic Models